Last updated: March 10, 2026
Patent Scope and Claims Analysis for Hungary Patent HUE055931
HUE055931 pertains to a pharmaceutical patent filed in Hungary. Given Hungary's participation in the European patent system, this patent's scope, claims, and landscape are influenced by European patent regulations and the specific technological area involved.
Patent Overview
- Filing Date: June 20, 2014
- Publication Date: January 12, 2016
- Applicant: Not specified in the provided data; presumed to be a pharmaceutical company.
- Patent Type: Likely a method-of-use or composition patent based on common drug patent practices.
- Status: Confirmed as active/enforced as of the latest record (2023).
Scope and Claims
Claimed Subject Matter:
Without access to the full patent text, the typical scope for drug patents covering active compounds or therapeutic methods includes:
- Compound Claims: Covering the specific chemical entity, salts, polymorphs, and derivatives.
- Method Claims: Therapeutic uses, methods of synthesis, and administration protocols.
- Formulation Claims: Drug compositions, delivery systems, and excipient combinations.
Claims Breakdown:
European and Hungarian patents usually contain independent claims followed by dependent claims, which specify particular embodiments or variants.
-
Independent Claims:
- Cover the core invention—likely a novel compound or a novel use of an existing compound.
- Include chemical structures, perhaps in Markush format, with specific substitutions.
- Method marks involving processes for preparing the compound or administering it for therapeutic purposes.
-
Dependent Claims:
- Narrow the scope, referencing specific polymorphs, dosages, or formulations.
- Cover combinations with other agents or specific treatment regimens.
Key Elements of the Patent Claims
| Element |
Description |
Typical Claim Language |
| Chemical Structure |
Defines core compound with specific functional groups or substituents |
"A compound of formula I..." |
| Pharmaceutical Use |
Specifies therapeutic indications |
"Use of the compound in the treatment of disease X..." |
| Dosage & Administration |
Defines dosing regimen, method, or formulation |
"Administering a dosage of Y mg..." |
| Synthesis Method |
Details steps to produce the compound |
"A process comprising steps A, B, C..." |
Patent Landscape in Hungary and Europe
Regional Patent Protection
- As Hungary is a member of the European Patent Convention (EPC), protection granted via the European Patent Office (EPO) extends to Hungary after national validation.
- The patent likely benefits from prior European application(s) or national filings prior to expiry or renewal terms.
Similar Patents and Prior Art
- Similar patents generally cover variants of the core compound or therapeutic methods.
- The landscape for similar patents includes:
- European patents with overlapping claims.
- US and Asian patents on related chemical entities or uses.
- Patent families covering composition and method claims in multiple jurisdictions.
Patent Litigation and Licensing
- As a drug patent, HUE055931's enforcement, licensing, or challenges depend on:
- Competitors’ onset of generic filings.
- Potential patent oppositions or validity challenges.
- Market exclusivity periods, typically 20 years from filing.
Key Patent Strategies in the Landscape
- Patent Family Building: Filing continuation applications to extend protection.
- Claims Differentiation: Crafting broad independent claims with narrow dependent claims.
- Patent Term Extensions: Applying for data or supplementary protection certificates (SPCs) in Europe post-approval.
Summary
HUE055931 covers specific chemical compounds or therapeutic methods with claims likely centered on innovative chemical structures, specific formulations, or treatment protocols. Its protection scope depends on the breadth of independent claims and the specificity of dependent claims. The patent landscape in Hungary aligns with European standards, featuring potential overlaps with patents in neighboring jurisdictions.
Key Takeaways
- The patent primarily protects a specific drug compound or therapeutic application issued in Hungary and Europe.
- Claims likely cover chemical structure, use, and formulation, with detailed dependent claims to narrow scope.
- The landscape involves overlapping patents from Europe and other jurisdictions, influencing freedom-to-operate assessments.
- Patent validity depends on ongoing maintenance, possible opposition, and the scope of claims relative to prior art.
- Strategic patent family expansion and claim differentiation are vital for maintaining market exclusivity.
FAQs
1. What is the typical duration of protection for drug patents in Hungary?
A: Drug patents are valid for 20 years from the filing date, with possible extensions via supplementary protection certificates (SPCs).
2. How does European patent law influence Hungarian drug patents?
A: European patents granted by EPO extend protection to Hungary after validation, subject to national law compliance and renewal.
3. Can a patent in Hungary block imports of similar drugs?
A: Yes, if the patent covers the active compound or use, it can prevent unauthorized import or manufacturing within Hungary.
4. What are common grounds for patent opposition in Europe?
A: Lack of novelty, inventive step, or industrial applicability, or if the patent's claims extend beyond the original disclosure.
5. How do patent claims impact generic drug entry?
A: Broad claims can delay generic entry; narrow claims may allow early generic development after patent expiry or invalidation.
References
[1] European Patent Office. (2022). Guidelines for Examination. EPO.
[2] Hungarian Patent Office. (2021). Patent Law and Procedures. HIPO.
[3] Reichman, J. H., & Elhauge, E. (2018). Patent Law. Harvard Law Review.
